Please assess the completion status of the following clinical trial:

Trial Title: Testing Glial Pathways to HAAF in Human Subjects Using Carbon 13 Magnetic Resonance Spectroscopy

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male~* BMI 20.0-24.9 kg/m2~* 18-40 years old~* Willing to reside at Pennington Biomedical for 4 days~Exclusion Criteria:~* Type 1 diabetes mellitus~* Type 2 diabetes mellitus~* Fasting glucose ≥ 110 mg/dL (determined at screening visit)~* Hyperketonuria \>15 mg/dL, (determined at screening visit)~* Contraindication to MRI~* History of or current eating disorder~* History of obsessive compulsive disorder~* Current use of any medication (excluding over-the-counter pain medication)~* Contraindication to prolonged fasting~* Consume \>10 alcoholic drinks/week

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Healthy Men (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).